Solid Biosciences Inc (SLDB)

Schlusskurs vom Vortag:

$8.54

Offen:

$8.52

24-Stunden-Volumen:

189.87K

Marktkapitalisierung:

$339.06M

Einnahmen:

$14.79M

Nettoeinkommen (Verlust:

$-96.02M

KGV:

-1.4539

EPS:

-6.1766

Netto-Cashflow:

$-95.70M

1W Leistung:

+3.22%

1M Leistung:

-33.82%

6M Leistung:

+349.00%

1J Leistung:

+91.06%

1-Tages-Spanne:

$8.41

$9.08

52-Wochen-Spanne:

$1.81

$15.05

Solid Biosciences Inc Stock (SLDB) Company Profile

Firmenname

Solid Biosciences Inc

Sektor

Healthcare (1191)

Branche

Biotechnology (688)

Telefon

617-337-4680

Adresse

141 Portland Street, Fifth Floor, Cambridge, MA

Mitarbeiter

60

Twitter

@SolidBioDMD

Nächster Verdiensttermin

2024-05-09

Neueste SEC-Einreichungen

SLDB's Discussions on Twitter

Solid Biosciences Inc Stock (SLDB) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2021-07-12	Eingeleitet	Piper Sandler	Neutral
2021-05-27	Eingeleitet	Jefferies	Buy
2021-03-16	Hochstufung	SVB Leerink	Mkt Perform → Outperform
2021-03-09	Eingeleitet	Barclays	Overweight
2021-01-08	Hochstufung	Credit Suisse	Underperform → Neutral
2020-07-28	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2020-05-07	Herabstufung	Evercore ISI	Outperform → In-line
2019-10-11	Eingeleitet	Evercore ISI	Outperform
2019-08-29	Herabstufung	Citigroup	Neutral → Sell
2019-08-19	Hochstufung	SVB Leerink	Mkt Perform → Outperform
2019-08-16	Hochstufung	Chardan Capital Markets	Neutral → Buy
2019-05-14	Herabstufung	Credit Suisse	Neutral → Underperform
2019-05-14	Herabstufung	Goldman	Neutral → Sell
2019-02-08	Hochstufung	Citigroup	Sell → Neutral
2019-02-08	Herabstufung	SVB Leerink	Outperform → Mkt Perform
2018-11-06	Eingeleitet	Citigroup	Sell
2018-09-06	Eingeleitet	Credit Suisse	Neutral

Alle ansehen

Solid Biosciences Inc Aktie (SLDB) Neueste Nachrichten

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire Inc.

Solid Biosciences (SLDB) Falls Despite FDA Rare Tag for DMD Drug

Zacks Investment Research

Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003

GlobeNewswire Inc.

Blend Labs Reports Q4 Results, Joins Alta Equipment, Despegar.com And Other Big Stocks Moving Higher On Friday

Benzinga

Solid Biosciences Provides Fourth Quarter and Full-Year 2023 Business Update and Financial Results

GlobeNewswire Inc.

Beat the Market Like Zacks: Walmart, Novo Nordisk, Procter & Gamble in Focus

Zacks Investment Research

Finanzdaten der Solid Biosciences Inc-Aktie (SLDB)

Solid Biosciences Inc (SLDB) Umsatz 2024

Solid Biosciences Inc (SLDB) Nettogewinn 2024

Solid Biosciences Inc (SLDB) Free Cashflow 2024

Solid Biosciences Inc (SLDB) Gewinn je Aktie 2024